Publications by authors named "Mark Matson"

Claim this Profile
F
First-in-Human Phase I Clinical Trial of the Adenosine A1R/A3R Agonist AST-004 in Healthy Subjects.
Lisa M Manna, Juan Hernandez, Dawn E Hunt, Géza Lakner, Mark A Matson

Stroke· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging real-time patient data during the COVID-19 pandemic.
John C O'Horo, Douglas W Challener, Cory Kudrna, Jason R Buckmeier, Steve G Peters, Mark W Matson

Infect Control Hosp Epidemiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronavirus Disease 2019 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida Through August 2021.
Wendelyn Bosch, Jennifer B Cowart, Shivang Bhakta, Rickey E Carter, Hani M Wadei, Mark W Matson

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low antispike antibody levels correlate with poor outcomes in COVID-19 breakthrough hospitalizations.
Devang K Sanghavi, Shivang Bhakta, Hani M Wadei, Wendelyn Bosch, Jennifer B Cowart, Mark W Matson

J Intern Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants.
Shivang Bhakta, Devang K Sanghavi, Patrick W Johnson, Katie L Kunze, Matthew R Neville, Mark W Matson

Int J Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial.
Mark A Matson, Eran Schenker, Michal Stein, Vladislava Zamfirova, Huy-Binh Nguyen

Hum Vaccin Immunother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VDR in salivary gland homeostasis and cancer.
Kara A DeSantis, Samantha L Robilotto, Mark Matson, Noor M Kotb, Cathryn M Lapierre

J Steroid Biochem Mol Biol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers.
Nandita Bose, Nadine R Ottoson, Xiaohong Qiu, Ben Harrison, Jamie R Lowe, Mark A Matson

J Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune characteristics correlating with HSV-1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labialis episodes.
Hugh McTavish, Katherine W Zerebiec, Jay C Zeller, Laurie L Shekels, Mark A Matson

Immun Inflamm Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Pharmacodynamics, and Safety of ASP015K (Peficitinib), a New Janus Kinase Inhibitor, in Healthy Subjects.
Ying Jun Cao, Taiji Sawamoto, Udaya Valluri, Kathy Cho, Michaelene Lewand, Mark Matson

Clin Pharmacol Drug Dev· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta-1a in subjects with normal or impaired renal function.
Xiao Hu, Ali Seddighzadeh, Scott Stecher, Ying Zhu, Jaya Goyal, Mark Matson

J Clin Pharmacol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatment.
John G Devane, Mary L Martin, Mark A Matson

Curr Med Res Opin· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.
Clapton S Dias, Adam J Shaywitz, Scott M Wasserman, Brian P Smith, Bing Gao, Mark Matson

J Am Coll Cardiol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients.
Marc L Reitman, Victor Dishy, Allison Moreau, William S Denney, Chengcheng Liu, Mark A Matson

J Clin Pharmacol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiation.
Mark A Matson, Thomas R Zimmerman, Dianne Tuccillo, Yongqiang Tang, Aaron Deykin

Curr Med Res Opin· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of FV-100, a novel oral anti-herpes zoster nucleoside analogue, administered in single and multiple doses to healthy young adult and elderly adult volunteers.
Helen S Pentikis, Mark Matson, George Atiee, Brian Boehlecke, Jeff T Hutchins

Antimicrob Agents Chemother· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis